[Skip to Content]
[Skip to Content Landing]
August 1960

The Significance of Urine Electrophoresis in Patients with Multiple Myeloma

Author Affiliations
From the Veterans Administration Hospital and the Departments of Medicine and Pathology, University of Minnesota.
Arch Intern Med. 1960;106(2):172-178. doi:10.1001/archinte.1960.03820020012004

Some of the merits of electrophoresis of the urine in patients with multiple myeloma have been emphasized previously.1-4 About 10% to 25% of these patients fail to show a characteristic protein peak in the serum 1-7 and would escape detection by serum electrophoresis alone. Fortunately this very group of patients excretes Bence Jones proteins in the urine in practically every instance. (The term "Bence Jones protein" is used somewhat loosely in this report to include all urinary paraproteins.) Upon electrophoresis Bence Jones proteins present themselves as sharply defined homogenous bands anywhere between the ranges of α- and γ-globulins. In some instances of multiple myeloma these urinary paraproteins are demonstrated very distinctly by means of urine electrophoresis but are defined vaguely or not at all by the physicochemical criteria of Bence Jones proteins, especially in poorly concentrated urine. Thus they may escape detection.1-3 Simultaneous electrophoresis of serum and urine

Osseman, E. F., and Lawlor, D. P.:  Abnormal Serum and Urine Proteins in 35 Cases of Multiple Myeloma, as Studied by Filter Paper Electrophoresis ,  Am. J. Med. 18:462-476 ( (March) ) 1955.Crossref
Thije, O. J. T.:  Urinary and Serum Proteins in Myelomatosis ,  Acta med. scandinav. 153: 253-269 ( (Jan. 25) ) 1956.Crossref
Owen, J. A., and Rider, D. W.:  Electrophoretic Analysis of Serum and Urinary Proteins in the Diagnosis of Myelomatosis ,  J. Clin. Path. (London) 10:373-378 ( (Nov.) ) 1957.Crossref
Chiesura, P., and Prato, V.:  Mieloma multiplo: valutazione clinica delle alterazioni proteiche ematologiche e renali; I. Le alterazioni proteiche ,  Minerva med. 49:1562-1572 ( (April 25) ) 1958.
Zinneman, H. H., and Hall, W. H.:  Recurrent Pneumonia in Multiple Myeloma and Some Observations on Immunologic Response ,  Ann. Int. Med. 41:1152-1163 ( (Dec.) ) 1954.Crossref
Zinneman, H. H.:  Dysproteinemia ,  Postgrad. Med. 23:550-560 ( (May) ) 1958.
Glenchur, H.; Zinneman, H. H., and Hall, W. H.:  A Review of 51 Cases of Multiple Myeloma: Emphasis on Pneumonia and Other Infections as Complications ,  A.M.A. Arch. Int. Med. 103:173-183 ( (Feb.) ) 1959.Crossref
Slater, R. J., and Kunkel, H. G.:  Filter Paper Electrophoresis with Special Reference to Urinary Proteins ,  J. Lab. & Clin. Med. 41:619-631 ( (April) ) 1953.
Sandkühler, S., and Hugentobler, F.:  Neuere Erhebungen zur Proteinurie ,  Ztschr. klin. Med. 148:603-621, 1951.
Rundles, R. W.; Dillon, H. L., and Dillon, E. S.:  Multiple Myeloma: Effect of Urethane Therapy on Plasma Cell Growth, Abnormal Serum Protein Components and Bence Jones Proteinuria ,  J. Clin. Invest. 29:1243-1260 ( (Sept.) ) 1950.
Rundles, R. W.; Cooper, G. R., and Willett, R. W.:  Multiple Myeloma: IV. Abnormal Serum Components and Bence Jones Protein ,  J. Clin. Invest. 30:1125-1142 ( (Oct.) ) 1951.
Warter, J.; Métais, P., and Mantz, J. M.:  Maladie de Kahler et paraprotéinurie ,  Semaine hôp. Paris 34:2919-2930 ( (Dec. 4) ) 1958.
Lane, S. L.:  Plasmocytoma of the Mandible ,  Oral Surg. 5:434-442 ( (April) ) 1952.
Potter, M.; Fahey, J. L., and Pilgrim, H. I.:  Abnormal Serum Protein and Bone Destruction in Transmissible Mouse Plasma Cell Neoplasm (Multiple Myeloma) ,  Proc. Soc. Exper. Biol. & Med. 94:327-333 ( (Feb.) ) 1957.
Nathans, D.; Fahey, J. L., and Potter, M.:  The Formation of Myeloma Protein by a Mouse Plasma Cell Tumor ,  J. Exper. Med. 108:121-130 ( (July) ) 1958.
Vis, H., and Crokaert, R.:  Contribution à l'étude des protéines de Bence-Jones ,  Acta clin. belg. 11:455-503 ( (Nov.-Dec.) ) 1956.
Putnam, F. W.:  Aberrations of Protein Metabolism in Multiple Myeloma: Interrelationships of Abnormal Serum Globulins and Bence-Jones Proteins ,  Physiol. Rev. 37:512-538 ( (Oct.) ) 1957.
Roberts, E.; Ramasarma, G. B., and Lewis, H. B.:  Amino Acids of Bence-Jones Protein ,  Proc. Soc. Exper. Biol. & Med. 74:237-241 ( (May) ) 1950.
Jirgensons, B.; Landua, A. J., and Awapara, J.:  Study of Physicochemical and Chemical Properties of Bence-Jones Protein from Multiple Myeloma ,  Biochim. et biophys. acta 9:625-632 ( (Dec.) ) 1952.
Putnam, F. W.:  Abnormal Human Serum Globulins ,  Science 122:275-277 ( (Aug. 12) ) 1955.
Putnam, F. W., and Hardy, S.:  Proteins in Multiple Myeloma: III. Origin of Bence Jones Proteins ,  J. Biol. Chem. 212:361-369 ( (Jan.) ) 1955.
Hardy, S., and Putnam, F. W.:  Proteins in Multiple Myeloma: IV. Interaction with Metabolic Nitrogen ,  J. Biol. Chem. 212:371-378 ( (Jan.) ) 1955.
Osserman, E. F.; Graff, A.; Marshall, M.; Lawlor, D., and Graff, S.:  Incorporation of N15-L-Aspartic Acid into the Abnormal Serum and Urine Proteins of Multiple Myeloma: Studies of the Inter-Relationship of These Proteins ,  J. Clin. Invest. 36:352-360 ( (March) ) 1957.Crossref
Dirr, K., and Götz-Schriever, G.:  Myelomund Nephroseeiweiss im Urin und ihre Erkennung durch Aminosäurebestimmung ,  Ztschr. klin. Med. 145:186-193, 1949.
Zollinger, H. U.:  Die pathologische Anatomie der Makroglobulinämie Waldenström ,  Helvet. med. acta 25:153-183, 1958.